· 羅氏Obinutuzumab獲優先審評 | 2019-12-16 04:39:44 |
· Gazyva(obinutuzumab)狼瘡腎炎試驗獲肯定結... | 2019-11-11 14:44:48 |
· 美批準Venclexta聯合Obinutuzumab用于白血... | 2019-05-17 12:12:36 |
· 美批準Gazyva(obinutuzumab)用于濾泡性淋巴... | 2017-11-21 16:54:31 |
· 歐批準Gazyvaro(Obinutuzumab)用于濾泡性... | 2016-06-21 11:40:24 |
· Gazyva濾泡性淋巴瘤研究結果發布 | 2016-06-02 09:45:44 |
· 美批準Gazyva(obinutuzumab)用于濾泡性淋巴... | 2016-03-04 15:46:28 |
· Gazyva非霍奇金淋巴瘤3期試驗獲肯定結果 | 2015-02-06 14:23:02 |
· 近年4種慢性淋巴細胞白血病藥物獲批 | 2015-01-22 16:59:56 |
· 歐洲批準Gazyvaro(Obinutuzumab)用于慢性... | 2014-07-31 14:10:12 |
· CHMP支持批準Gazyvaro(obinutuzumab)... | 2014-05-26 14:42:44 |
· Obinutuzumab聯合苯丁酸氮芥延長CLL患者生存 | 2014-01-14 14:20:29 |
· Obinutuzumab可取代利妥昔單抗用于CLL一線治療 | 2013-12-27 10:51:04 |
· 美批準Gazyva(obinutuzumab)用于慢性淋巴性... | 2013-11-04 14:13:53 |
· Obinutuzumab慢性淋巴細胞白血病獲優先審評 | 2013-07-05 14:20:25 |
· Obinutuzumab發布白血病有利試驗結果 | 2013-05-20 14:24:11 |
· Obinutuzumab進行非霍奇金淋巴瘤3期試驗 | 2012-11-29 11:15:06 |